Health Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) has announced a major shift in how Class III Natural Health Product (NHP) submissions will be reviewed. As of March 5, 2025, submissions will no longer be assessed on a first-come, first-served basis. Instead, NNHPD will prioritize applications that demonstrate clear plans for sale or manufacturing in Canada within six months of approval. This change aims to streamline the regulatory process, ensuring resources are allocated to products that will directly benefit Canadian consumers.
For companies planning to bring Class III NHPs to market, understanding these new workload management criteria is critical. In this blog, we break down what’s changing, how it affects you, and what steps you should take to ensure your submission remains a priority.
The NNHPD has introduced this new approach to improve efficiency in evaluating Class III NHP applications and amendments.
These changes:
The ultimate goal is to ensure that the regulatory process supports the availability of safe, effective, and high-quality natural health products for Canadians.
Moving forward, NNHPD will only prioritize Class III applications that meet at least one of the following criteria:
If a submission does not meet these criteria, it will be deprioritized, meaning it will only be reviewed when resources allow. Companies will have the option to withdraw and refile later when they plan to bring the product to market in Canada.
To ensure your Class III NHP submission remains a priority, companies must take the following steps:
Failure to submit the Workload Management Form on time will result in delays or de-prioritization of your application.
Navigating regulatory changes can be complex. If you need help ensuring your Class III NHP submission meets the new workload management criteria, working with an experienced regulatory consulting firm can streamline the process and minimize delays.
At dicentra, we specialize in helping businesses achieve NHP compliance and secure regulatory approvals. As a leading regulatory consulting firm and Contract Research Organization (CRO) based in Canada, dicentra has been supporting clients for over 23 years. Our team can assist you with:
With the March 5, 2025, come and gone, now is the time to ensure your application is in order. Contact us today to discuss how we can help you navigate these new requirements with confidence.